Deloitte's 12th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Rises to Highest Level Since 2014
/PRNewswire/ -- Key Takeaways: Projected returns on investment in pharma R&D in 2021 have risen to 7 % from 2.7 %, the largest annual increase since the study...
Source: prnewswire.com